Literature DB >> 10825583

Germ-free mice do not develop ankylosing enthesopathy, a spontaneous joint disease.

Z Reháková1, J Capková, R Stĕpánková, J Sinkora, A Louzecká, P Ivanyi, S Weinreich.   

Abstract

Ankylosing enthesopathy (ANKENT) is a naturally occurring joint disease in mice with numerous parallels to human ankylosing spondylitis (AS). Similarities between AS and ANKENT include not only affected tissue (joint entheses) but also association of the disease with genetic background, including MHC genes, gender, and age. Young males with the C57Bl/10 background have been described to suffer from ANKENT and, among H-2 congenic strains, high frequency of afflicted joints has been recorded in B10.BR (H-2(k)) males. Interestingly, the incidence of ANKENT is higher in conventional (CV) males that in their specific-pathogen-free (SPF) counterparts. The latter finding suggests that microbes could play a role as an ANKENT-triggering agent. To further examine this hypothesis we have established a germ-free (GF) colony of B10.BR mice and observed ANKENT incidence in both GF males and their conventionalized (ex-GF) male littermates; 20% of ex-GF males developed ANKENT before 1 year of age. In contrast, no joint disease was observed under GF conditions (p < 0.0001). Our results show that live microflora is required in ANKENT pathogenesis.

Entities:  

Mesh:

Year:  2000        PMID: 10825583     DOI: 10.1016/s0198-8859(00)00122-1

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  22 in total

Review 1.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stěpánková; Hana Kozáková; Tomáš Hudcovic; Luca Vannucci; Ludmila Tučková; Pavel Rossmann; Tomáš Hrnčíř; Miloslav Kverka; Zuzana Zákostelská; Klára Klimešová; Jaroslava Přibylová; Jiřina Bártová; Daniel Sanchez; Petra Fundová; Dana Borovská; Dagmar Srůtková; Zdeněk Zídek; Martin Schwarzer; Pavel Drastich; David P Funda
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 2.  The role of the gut microbiome in systemic inflammatory disease.

Authors:  Jose C Clemente; Julia Manasson; Jose U Scher
Journal:  BMJ       Date:  2018-01-08

Review 3.  Spondyloarthritis and the microbiome: new insights from an ancient hypothesis.

Authors:  Julia Manasson; Jose U Scher
Journal:  Curr Rheumatol Rep       Date:  2015-02       Impact factor: 4.592

Review 4.  Influence of microbial environment on autoimmunity.

Authors:  Alexander V Chervonsky
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

5.  Sexual dimorphism, but not testosterone itself, is responsible for ankylosing enthesitis of the ankle in B10.BR (H-2k) male mice.

Authors:  J Capkova; P Ivanyi; Z Rehakova
Journal:  Ann Rheum Dis       Date:  2006-01       Impact factor: 19.103

Review 6.  Gut inflammation and microbiome in spondyloarthritis.

Authors:  Jayakanthan Kabeerdoss; Pulukool Sandhya; Debashish Danda
Journal:  Rheumatol Int       Date:  2015-12-30       Impact factor: 2.631

7.  Experimental colitis does not increase the prevalence of ANKENT, a spontaneous joint disease in mice.

Authors:  J Capková; R Stepánková; T Hudcovic; J Sinkora; Z Reháková
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

Review 8.  Gut microbiota, metabolites and host immunity.

Authors:  Michelle G Rooks; Wendy S Garrett
Journal:  Nat Rev Immunol       Date:  2016-05-27       Impact factor: 53.106

Review 9.  Sexual dimorphism in autoimmunity.

Authors:  Kira Rubtsova; Philippa Marrack; Anatoly V Rubtsov
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

Review 10.  Microbiota and autoimmunity.

Authors:  Alexander V Chervonsky
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-03-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.